Evidence map›Paper›PMID 41308190›Full record

ArticleJMIR formative research2025

AI-Powered Thermography for Diabetic Foot Risk Stratification: Multicenter Cross-Sectional Study.

Meshari F Alwashmi, Mustafa Alghali, Waseem Abu-Ashour, Abdullah Mohammed Arabe, Abdullah Al Soheimi, Nasibh Abdulrahman Alharbi, Hani Mohammed Badahdah

Abstract readMulticenter Study
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meshari F AlwashmiAmplifai Health, Riyadh, Saudi Arabia.ORCID 0000-0001-5052-5911
Mustafa AlghaliAmplifai Health, Riyadh, Saudi Arabia.ORCID 0009-0009-5488-2575
Waseem Abu-AshourMemorial University, Health Sciences Centre, St. John's, NL, Canada.ORCID 0000-0002-3119-5694
Abdullah Mohammed ArabeMinistry of Health, Riyadh, null, Saudi Arabia.ORCID 0009-0002-9893-7506
Abdullah Al SoheimiMinistry of Health, Riyadh, null, Saudi Arabia.ORCID 0009-0005-0269-7360
Nasibh Abdulrahman AlharbiMinistry of Health, Riyadh, null, Saudi Arabia.ORCID 0009-0000-2826-6546
Hani Mohammed BadahdahMinistry of Health, Riyadh, null, Saudi Arabia.ORCID 0000-0001-5620-2347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic foot complications are among the most severe and costly outcomes associated with diabetes, with high prevalence particularly in the Middle East and North Africa region. Current screening tools are often limited by subjectivity, invasiveness, or scalability challenges, underscoring the need for innovative approaches.

objectiveThis multicenter study aimed to evaluate the performance of an artificial intelligence (AI)-powered thermographic system, Thermal Foot Scan (TFScan), in identifying patients at elevated risk of diabetic foot complications through noninvasive temperature profiling.

methodsA multicenter cross-sectional analysis of deidentified routine screening data across 4 regions in Saudi Arabia was conducted enrolling 1120 individuals with diabetes. Participants underwent thermal imaging using a smartphone-compatible infrared camera with AI algorithms analyzing angiosomal temperature patterns and asymmetries. Risk was stratified into 4 categories (very low, low, moderate, and high). Associations between TFScan classifications and clinical risk factors, symptoms of neuropathy, and thermal abnormalities were assessed.

resultsWhile 90.7% (1016/1120) of the participants were classified as very low or low risk, 9.3% (104/1120) were identified as moderate or high risk. This higher-risk group exhibited significantly greater prevalence of key diabetic complications (P<.001). Peripheral artery disease was present in 20.2% (21/104) of moderate- and high-risk participants compared to just 0.8% (8/1016) of lower-risk individuals. Cardiovascular disease (60/104, 57.7% vs 313/1016, 30.8%), neuropathy (12/104, 11.5% vs 37/1016, 3.6%), foot deformities (15/104, 14.4% vs 6/1016, 0.6%), and symptoms of loss of protective sensation (53/104, 51% vs 354/1016, 34.8%) were all significantly more frequent in the high-risk subgroup than in the low-risk group, respectively. Thermal imaging further revealed pronounced abnormalities: temperature asymmetries of ≥2.2 °C were observed in 7.1% (79/1120) of the patients overall, with the highest asymmetry and thermal change index scores concentrated in the moderate- and high-risk groups. These individuals also exhibited greater deviations in angiosomal temperature differences-exceeding 2.2 °C in key vascular territories such as the medial plantar and lateral plantar arteries-suggesting both early inflammatory states and critical perfusion deficits.

conclusionsThe TFScan system effectively stratified patients with diabetes into clinically meaningful risk categories, with moderate- and high-risk groups exhibiting a significantly higher burden of vascular, neuropathic, and thermal abnormalities. However, the cross-sectional design, partial reliance on self-report, and low prevalence of advanced complications may limit causal inference. These findings highlight the potential of AI-enhanced thermography to serve as a scalable, objective screening tool for proactive diabetic foot management. Further longitudinal studies are warranted to validate its predictive power and support widespread clinical adoption.

Indexed as

Artificial IntelligenceDiabetic FootThermographyAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsSaudi ArabiaAIartificial intelligencediabetic foot ulcerdigital healthrisk stratificationscreeningthermography

Identifiers

PMID41308190
PMCPMC12699249

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.